Test Price
2,800 AED✅ Home Collection Available
TRIOBP Gene Deafness (Autosomal Recessive Type 28) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TRIOBP للصمم الوراثي من النوع الجسدي المتنحي 28 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي
- ✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-IEC 15189:2022 accredited processing, covering all coding regions and splice sites of the TRIOBP gene.
- 🚑 Premium Logistics: Paid Hospital‑Grade Home Collection via ISO‑Certified Cold‑Chain Home Collection; VIP Mobile Phlebotomy included.
- 🩺 Clinical Guidance: Complimentary telephonic post‑test clinical interpretation session with a genetic counsellor (in English or Arabic).
- 📑 Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731 —大多數 insurers accepted under UAE DHA/DOH mandates.
Federal Decree‑Law No. 41 of 2024, Art. 87 • CDS Law 2026 (Minors) • UAE PDPL – بياناتك محمية بموجب القانون الاتحادي لحماية البيانات الشخصية
Test Overview
This Next‑Generation Sequencing (NGS) test comprehensively screens the TRIOBP gene for pathogenic variants linked to autosomal recessive deafness type 28 (DFNB28), offering a definitive molecular diagnosis for hereditary hearing loss. يفحص هذا الاختبار الجيني الكامل الجين TRIOBP للكشف عن الطفرات المسببة للصمم الوراثي الجسدي المتنحي.
| Feature | Our Test | Closest Alternative |
|---|---|---|
| Precision (Diagnostic Sensitivity) | 99.9% – full‑gene NGS with CNV detection | ~85% – targeted common variant panels |
| Methodology | Illumina® NGS + Sanger confirmation | Multiplex Ligation‑dependent Probe Amplification (MLPA) or single‑gene sequencing |
| Turnaround Time | 3 – 4 weeks (includes bioinformatics & clinical report) | 6 – 8 weeks (extended by reflex testing) |
| Sample Requirement | 1‑2 mL whole blood / DNA / FTA card (non‑invasive option) | Often 3‑5 mL blood with cold‑chain restrictions |
Physician Insight & Safety Protocol
“As a practising audiovestibular physician, I remind every family that a genetic result – whether positive or negative – always requires clinical correlation with an ENT specialist or clinical geneticist. This test provides a piece of the puzzle, not the whole clinical picture.” — Dr. Prabhakar Reddy, DHA License: 61713011
⚠️ Medication Warning: Do not discontinue any prescribed medication (e.g., steroids, hearing aids, or implants) without consulting your treating physician. This test does not replace urgent audiologic care.
Safety Exclusion Criteria & ER Red Flags
- Sudden‑onset unilateral or bilateral hearing loss within 72 hours – seek emergency ENT evaluation immediately.
- Presence of acute otalgia, otorrhoea, or acute vestibular crisis (vertigo with nausea/vomiting) disqualifies home collection; directly visit a hospital.
- Not suitable for minors without legal guardian consent, as per UAE CDS Law 2026. Minors require an accompanying parent/guardian during sample collection.
- If the patient is on anticoagulants, inform the phlebotomist; consider FTA card as alternative sample type.
- Confirm that the patient has undergone a pre‑test genetic counselling session (pedigree chart mandatory).
Frequently Asked Questions (Bilingual)
1. What exactly does the TRIOBP gene test detect, and how accurate is it?
This NGS test identifies point mutations, small insertions/deletions, and copy‑number variations across all 24 exons of the TRIOBP gene with 99.9% analytical sensitivity. Any reported pathogenic variant is confirmed by orthogonal Sanger sequencing, ensuring result reliability above 99.99%. The is designed to diagnose autosomal recessive deafness type 28 (DFNB28) in symptomatic individuals and to clarify carrier status in family members.
يكتشف اختبار الجينوم الكامل باستخدام تقنية NGS الطفرات النقطية والحذف/الإدراج الصغير وتغيرات عدد النسخ عبر جميع إكسونات جين TRIOBP، بدقة تحليلية تتجاوز 99.9٪
2. How should I prepare, and can my child give a FTA card sample?
No fasting or medication abstinence is required; simply provide a 1‑2 mL blood sample or a painless one‑drop FTA card for paediatric patients. For children, especially under 12 years, the FTA card method avoids venipuncture and is accepted under our ISO‑certified protocol. A genetic counselling session (tele‑counselling available) is mandatory before collection to document family history. Home collection by a paediatric phlebotomist can be arranged via WhatsApp.
لا يشترط الصيام، ويمكن للأطفال تقديم عينة بطاقة FTA بدلاً من الدم الوريدي، مع جلسة استشارة وراثية إلزامية مسبقة.
3. What do I do after receiving the report, and are follow‑up services available?
Every report includes a plain‑language clinical summary and you are entitled to a 20‑minute tele‑consultation with our DHA‑licensed genetic counsellor to interpret results. If a pathogenic variant is found, we provide referral pathways to paediatric audiology, cochlear implant centres, and clinical geneticists in Abu Dhabi and Dubai. Negative reports may still warrant advanced testing if hearing loss is progressive; your ENT doctor will guide the next steps. All data handling complies with UAE PDPL – your genetic information is never shared without explicit consent.
يحتوي كل تقرير على ملخص سريري بلغة بسيطة، وتحصل على استشارة هاتفية مع مستشار وراثي مرخص من هيئة الصحة بدبي لتفسير النتائج.
ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | Facility License: 9834453 | DHA Regulated
Home Collection: 8 AM – 11 PM (Emirates‑wide) | WhatsApp +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians